BARX1 promotes osteosarcoma cell proliferation and invasion by regulating HSPA6 expression

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Osteosarcoma (OS) is a primary bone cancer predominantly affecting adolescents.
• The role of Barx homeobox 1 (BARX1) in OS pathogenesis remains largely undefined.
• Understanding BARX1's function is crucial for developing novel therapeutic interventions.

Purpose of the Study:

• To elucidate the function and molecular mechanism of BARX1 in osteosarcoma.
• To investigate the relationship between BARX1 and heat shock 70-kDa protein 6 (HSPA6) in OS.
• To evaluate BARX1 and HSPA6 as potential therapeutic targets for OS.

Main Methods:

• Quantitative analysis of BARX1 expression in OS tissues versus normal tissues.
• In vitro studies involving BARX1 knockdown and overexpression in OS cells.
• RNA sequencing to identify downstream targets of BARX1.
• Dual-luciferase reporter assays to confirm direct transcriptional regulation.
• In vitro assays to assess the role of HSPA6 in OS cell proliferation and migration.
• Dual immunofluorescence labeling to validate protein co-expression in tumor tissues.

Main Results:

• BARX1 expression is significantly upregulated in osteosarcoma tissues.
• BARX1 downregulation inhibits OS cell proliferation and migration; overexpression enhances these processes.
• BARX1 directly upregulates HSPA6 expression in OS cells.
• Silencing HSPA6 abrogates the pro-proliferative and pro-migratory effects of BARX1.
• Co-overexpression of BARX1 and HSPA6 is observed in OS tumor tissues.

Conclusions:

• BARX1 promotes osteosarcoma cell proliferation and migration by inducing HSPA6 expression.
• HSPA6 acts as an oncogenic factor in osteosarcoma, mediating BARX1's effects.
• BARX1 and HSPA6 represent promising therapeutic targets for osteosarcoma treatment.